alexa Non-invasive parameters or liver biopsy in the diagnosis and staging of non-alcoholic fatty liver disease?

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Non-invasive parameters or liver biopsy in the diagnosis and staging of non-alcoholic fatty liver disease?

Liver Biopsy
liver biopsy is a procedure in which a small needle is inserted into the liver to collect a tissue sample. The tissue is then analyzed in a laboratory to help doctors diagnose a variety of disorders and diseases in the liver.

 

Background 
Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease worldwide and its prevalence continues to increase with the growing outbreak of obesity. NAFLD includes wide spectrum of diseases from fully benign simple steatosis to steatohepatitis, which could progress to liver cirrhosis and hepatocellular carcinoma. Liver biopsy is considered as the gold standard for assessing disease severity.

Patients and Methods
Serum concentrations of hyalurinic acid (HA), cytokeratine-18 fragments, TIMP1 and P3NP were measured and index Hepascore was calculated in 88 patients with NASH indicated for liver biopsy; in 10 patients measurement of hepatic venous pressure gradient was performed.

Results
The values of examined parameters were significantly elevated in patients with NASH compare to controls. Significant difference
in HA, Hepascore and other parameters was found between cirrhosis and all other fibrosis stages (p<0.05).
 
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger